Our MR analysis further confirmed the potential pathogenic role of FCGR2B in liver cancer, revealing its possible mechanism as an immune regulatory factor in the pathogenesis of hepatocellular carcinoma. Here, FCGR2B is linked to hepatocellular carcinoma.